Jigar Raythatha

Jigar Raythatha is the current President & CEO at Constellation Pharmaceuticals. Prior to this, they were with Third Rock Ventures, American Cancer Society, and Jounce Therapeutics, Inc.

Raythatha has over 16 years of experience in the biopharmaceutical industry. Jigar first started their career at Pfizer in 2004 as a summer intern in new product development and marketing. Jigar then went on to become a Kauffman Fellow from 2005 to 2007 and later a Principal at Red Abbey Venture Partners from 2007 to 2009. In 2009, they became Head of Corporate Development at Constellation Pharmaceuticals, a position they held until 2013 when they became Chief Executive Officer (CEO) at Jounce Therapeutics, Inc. As an early employee, they helped build the company from the ground up into a 90 person discovery to development organization. In 2017, they rejoined Constellation Pharmaceuticals as their CEO and helped establish a new vision for the company, recruit new leadership, and implement a financing plan that culminated in an acquisition for $1.7 billion.

Jigar Raythatha has a MBA from Columbia Business School and a B.A. in Biochemistry/Economics from Rutgers University.

Some direct reports include Brenda J. Sousa - Senior Vice President of Human Resources and Operations, Mohan Bala - SVP, Program Leadership, and Brad Prosek - Senior Vice President, Corporate Development.